Indications and uses
Helps prevent sunburn.
L'BEL SUPREMACIE NX JOUR Replenishing Treatment Daytime Face Cream SPF 15 Normal To Dry Skin
- Manufacturer
- Ventura International, LTD | MF Productions
- Effective date
- 2012-03-28
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 1
- Source
- full-release
- Hydrated at
- 2026-05-31 22:31:18
Label at a glance#
ProductLBEL SUPREMACIE NX JOUR Replenishing Treatment Daytime Face SPF 15 Normal To Dry Skin
Active ingredientENSULIZOLE, HOMOSALATE, OCTINOXATE, OXYBENZONE
Label structure9 sections
Label contents#
Full prescribing information#
Active Ingredients
ENSULIZOLE (2.0%)
HOMOSALATE (2.0%)
OCTINOXATE (7.5%)
OXYBENZONE (4.0%)
Uses
- Helps prevent sunburn.
Warnings
- Skin Cancer / Skin Aging Alert: Spending time in the sun increases your risk of skin cancer and early skin aging. This product has been shown only to help prevent sunburn, not skin cancer or early skin aging.
- For external use only.
When using this product
keep out of eyes. Rinse with water to remove.
Stop use and ask a doctor if
rash occurs.
Keep out of reach of children.
If swallowed, get medical help or contact a Poison Control Center right away.
Directions
- Apply liberally and evenly 15 minutes before sun exposure.
- Reapply at least every 2 years.
- Use a water resistant sunscreen if swimming or sweating.
- Children under 6 months of age: Ask a doctor.
Other Information
- Protect the product in this container from excessive heat and direct sun.
- Use in the morning after cleanser and toner. Apply a small quantity with your fingertips, spreading it over your face with rising, circular movements. Message in gently to help facilitate absorption.
Inactive Ingredients
Aqua (water), pisum sativum extract (pisum sativum (pea) extract), glycerin, cetyl alcohol, cyclopentasiloxane, triethanolamine, c12-15 alkyl benzoate, cyclohexasiloxane, glyceryl stearate, stearic acid, phenoxyethanol,polyacrylamide, erythritol,parfum (fragrance), peg-75 stearate, sodium polystyrene sulfonate,methylparaben, trifolium pratense flower extract(trifolium pratense (clover) flower extract), c13-14 isoparaffin,sorghum bicolor stalk juice, propylparaben, xanthan gum, ceteth-20,steareth-20, butylene glycol, laureth-7, acrylates/c10-30 alkyl acrylate crosspolymer, tetrasodium edta, dimethicone, butylparaben, hydrolyzed algin, ethylparaben, chlorella vulgaris extract, lecithin, maris aqua (sea water), isobutylparaben, carbomer, laureth-23, laureth-4, homarine hcl, ci 19140 (yellow 5),ci 14700 (red 4), biotinoyl tripeptide-1, ci 42090 (blue 1).
Purpose
Sunscreen
EXPERT ROUTINE L'BEL
L'Bel presents Expert Routine, a skin care program with two steps that work together for enhanced results:
1. Cleanse the skin according to its needs
2. Nourish according to the age.
SUPREMACIE NX JOUR
replenishing daytime face cream SPF 15
L'Bel, fully specialized in cosmetic facial treatment, presents the latest worldwide exclusive: the new Supremacie NX line of replenishing cosmetic treatments improved for women after age 40.
Dazzling beauty for women
The moisturizing formula of Supremacie NX Jour, Offers enhanced results:
A sensation of well-being that pervades the senses
Its rich and creamy texture, ideal for absorption has been specially created to provide a pleasant sensation of softness and comfort. Its exquisite fragrance rich in essences awakens the skin with new and pleasant emotions.
In two options according to your skin's needs:
USES: Helps prevent sunburn.
WARNINGS: Skin Cancer / Skin Aging Alert: Spending time in the sun increases your risk of skin cancer and early skin aging. This product has been shown only to help prevent sunburn, not skin cancer or early skin aging. For external use only. Do not use on damaged or broken skin. When using this product keep out of eyes. Rinse with water to remove. Stop use and ask a doctor if rash occurs. Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.
Directions: Apply liberally and evenly 15 minutes before sun exposure. Reapply at least every 2 hours.Use a water resistant sunscreen if swimming or sweating. Children under 6 months of age: Ask a doctor.
Other information: Protect the product in this container from excessive heat and direct sun. Use in the morning after cleanser and toner. Apply a small quantity with your fingertips, spreading it over your face with rising, circular movements. Message in gently to help facilitate absorption.
1. Cleanse the skin according to its needs
2. Nourish according to the age.
SUPREMACIE NX JOUR
replenishing daytime face cream SPF 15
L'Bel, fully specialized in cosmetic facial treatment, presents the latest worldwide exclusive: the new Supremacie NX line of replenishing cosmetic treatments improved for women after age 40.
Dazzling beauty for women
The moisturizing formula of Supremacie NX Jour, Offers enhanced results:
- Immediate, strong and long-lasting hydration in the areas where the face needs it most.
- Visibly diminishes the appearance of wrinkles.
- Uncovers skin that looks more firm.
A sensation of well-being that pervades the senses
Its rich and creamy texture, ideal for absorption has been specially created to provide a pleasant sensation of softness and comfort. Its exquisite fragrance rich in essences awakens the skin with new and pleasant emotions.
In two options according to your skin's needs:
- SUPREMACIE NX JOUR - replenishing daytime face cream SPF 15 Normal to Dry Skin
- SUPREMACIE NX JOUR - replenishing daytime face cream SPF 15 Normal to Oily Skin
USES: Helps prevent sunburn.
WARNINGS: Skin Cancer / Skin Aging Alert: Spending time in the sun increases your risk of skin cancer and early skin aging. This product has been shown only to help prevent sunburn, not skin cancer or early skin aging. For external use only. Do not use on damaged or broken skin. When using this product keep out of eyes. Rinse with water to remove. Stop use and ask a doctor if rash occurs. Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.
Directions: Apply liberally and evenly 15 minutes before sun exposure. Reapply at least every 2 hours.Use a water resistant sunscreen if swimming or sweating. Children under 6 months of age: Ask a doctor.
Other information: Protect the product in this container from excessive heat and direct sun. Use in the morning after cleanser and toner. Apply a small quantity with your fingertips, spreading it over your face with rising, circular movements. Message in gently to help facilitate absorption.
- HYPOALLERGENIC
- DERMATOLOGICALLY AND CLINICALLY TESTED
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
L'BEL
SUPREMACIE NX JOUR
replenishing daytime face cream SPF 15
normal to dry skin
50 g e (1.7 oz..)
US: Dist. by Ventura International Ltd. DBA Belcorp USA, San Francisco, CA 94111.
P.R.: Dist. by Ventura Corporation Ltd. San Juan, Puerto Rico 00926 MADE IN FRANCE.
LBEL SUPREMACIE NX JOUR Replenishing Treatment Daytime Face Cream SPF 15 Normal To Dry Skin
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| a90f088a-9578-47a2-8f6e-0a9d32aafec6 | Product name | 1 | 20181030 |
| f6c90bdc-1674-455a-aadd-1b1b59e5edeb | Product name | 2 | 20181030 |
| f1ec5c2f-d01e-a277-5826-c7eba86ed99b | Product name | 1 | 20140508 |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 43455-0005-0 | 2019-11-13 | C162847 | 48780-1 | 97449f38-c176-f6ea-e053-dbdaa90aa703 | L'BEL SUPREMACIE NX JOUR Replenishing Treatment Daytime Face Cream SPF 15 Normal To Dry Skin |
| 43455-0005-1 | 2019-11-13 | C162847 | 48780-1 | 97449f38-c176-f6ea-e053-dbdaa90aa703 | L'BEL SUPREMACIE NX JOUR Replenishing Treatment Daytime Face Cream SPF 15 Normal To Dry Skin |
| 43455-0005-2 | 2019-11-13 | C162847 | 48780-1 | 97449f38-c176-f6ea-e053-dbdaa90aa703 | L'BEL SUPREMACIE NX JOUR Replenishing Treatment Daytime Face Cream SPF 15 Normal To Dry Skin |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 43455-0005-0 | LBEL SUPREMACIE NX JOUR Replenishing Treatment Daytime Face SPF 15 Normal To Dry Skin | 1 g in 1 POUCH | CREAM | 1 | 1 | |
| 43455-0005-1 | LBEL SUPREMACIE NX JOUR Replenishing Treatment Daytime Face SPF 15 Normal To Dry Skin | 5 g in 1 JAR | CREAM | 5 | 1 | |
| 43455-0005-2 | LBEL SUPREMACIE NX JOUR Replenishing Treatment Daytime Face SPF 15 Normal To Dry Skin | 50 g in 1 JAR | CREAM | 50 | 1 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 43455-0005 | LBEL SUPREMACIE NX JOUR REPLENISHING TREATMENT DAYTIME FACE SPF 15 NORMAL TO DRY SKIN (ENSULIZOLE, HOMOSALATE, OCTINOXATE, OXYBENZONE) CREAM [VENTURA INTERNATIONAL, LTD] | 1 | Legacy NDC, 3 package rows | 20120404_09bd9805-9554-45f7-870e-b7f68bd87237.zip |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| ENSULIZOLE | ACTIVE INGREDIENT | 9YQ9DI1W42 | 1 | |
| HOMOSALATE | ACTIVE INGREDIENT | V06SV4M95S | 1 | |
| OCTINOXATE | ACTIVE INGREDIENT | 4Y5P7MUD51 | 1 | |
| OXYBENZONE | ACTIVE INGREDIENT | 95OOS7VE0Y | 1 | |
| ENSULIZOLE | ACTIVE MOIETY | 9YQ9DI1W42 | 1 | |
| HOMOSALATE | ACTIVE MOIETY | V06SV4M95S | 1 | |
| OCTINOXATE | ACTIVE MOIETY | 4Y5P7MUD51 | 1 | |
| OXYBENZONE | ACTIVE MOIETY | 95OOS7VE0Y | 1 | |
| ALKYL (C12-15) BENZOATE | INACTIVE INGREDIENT | A9EJ3J61HQ | 1 | |
| BIOTINOYL TRIPEPTIDE-1 | INACTIVE INGREDIENT | O6380721VA | 1 | |
| BUTYLENE GLYCOL | INACTIVE INGREDIENT | 3XUS85K0RA | 1 | |
| BUTYLPARABEN | INACTIVE INGREDIENT | 3QPI1U3FV8 | 1 | |
| C13-14 ISOPARAFFIN | INACTIVE INGREDIENT | E4F12ROE70 | 1 | |
| CARBOMER INTERPOLYMER TYPE A (55000 MPA.S) | INACTIVE INGREDIENT | 59TL3WG5CO | 1 | |
| CETETH-20 | INACTIVE INGREDIENT | I835H2IHHX | 1 | |
| CETYL ALCOHOL | INACTIVE INGREDIENT | 936JST6JCN | 1 | |
| CHLORELLA VULGARIS | INACTIVE INGREDIENT | RYQ4R60M02 | 1 | |
| CYCLOMETHICONE 5 | INACTIVE INGREDIENT | 0THT5PCI0R | 1 | |
| CYCLOMETHICONE 6 | INACTIVE INGREDIENT | XHK3U310BA | 1 | |
| DIMETHICONE | INACTIVE INGREDIENT | 92RU3N3Y1O | 1 | |
| EDETATE SODIUM | INACTIVE INGREDIENT | MP1J8420LU | 1 | |
| ERYTHRITOL | INACTIVE INGREDIENT | RA96B954X6 | 1 | |
| FD&C BLUE NO. 1 | INACTIVE INGREDIENT | H3R47K3TBD | 1 | |
| FD&C RED NO. 4 | INACTIVE INGREDIENT | X3W0AM1JLX | 1 | |
| FD&C YELLOW NO. 5 | INACTIVE INGREDIENT | I753WB2F1M | 1 | |
| GLYCERIN | INACTIVE INGREDIENT | PDC6A3C0OX | 1 | |
| GLYCERYL MONOSTEARATE | INACTIVE INGREDIENT | 230OU9XXE4 | 1 | |
| ISOBUTYLPARABEN | INACTIVE INGREDIENT | 0QQJ25X58G | 1 | |
| LAURETH-23 | INACTIVE INGREDIENT | N72LMW566G | 1 | |
| LAURETH-4 | INACTIVE INGREDIENT | 6HQ855798J | 1 | |
| LAURETH-7 | INACTIVE INGREDIENT | Z95S6G8201 | 1 | |
| METHYLPARABEN | INACTIVE INGREDIENT | A2I8C7HI9T | 1 | |
| PEA | INACTIVE INGREDIENT | W4X7H8GYFM | 1 | |
| PEG-75 STEARATE | INACTIVE INGREDIENT | OT38R0N74H | 1 | |
| PHENOXYETHANOL | INACTIVE INGREDIENT | HIE492ZZ3T | 1 | |
| PROPYLPARABEN | INACTIVE INGREDIENT | Z8IX2SC1OH | 1 | |
| SODIUM POLYSTYRENE SULFONATE | INACTIVE INGREDIENT | 1699G8679Z | 1 | |
| SORGHUM BICOLOR STEM JUICE | INACTIVE INGREDIENT | SKN30A294R | 1 | |
| STEARETH-20 | INACTIVE INGREDIENT | L0Q8IK9E08 | 1 | |
| STEARIC ACID | INACTIVE INGREDIENT | 4ELV7Z65AP | 1 | |
| TRIFOLIUM PRATENSE FLOWER | INACTIVE INGREDIENT | 4JS0838828 | 1 | |
| TROLAMINE | INACTIVE INGREDIENT | 9O3K93S3TK | 1 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | 1 | |
| XANTHAN GUM | INACTIVE INGREDIENT | TTV12P4NEE | 1 |
Products#
Every source-derived product name is available through these pages.
- LBEL SUPREMACIE NX JOUR Replenishing Treatment Daytime Face SPF 15 Normal To Dry Skin
- ENSULIZOLE, HOMOSALATE, OCTINOXATE, OXYBENZONE
- ENSULIZOLE
- HOMOSALATE
- OCTINOXATE
- OXYBENZONE
- WATER
- PEA
- GLYCERIN
- CETYL ALCOHOL
- CYCLOMETHICONE 5
- TROLAMINE
- ALKYL (C12-15) BENZOATE
- CYCLOMETHICONE 6
- GLYCERYL MONOSTEARATE
- STEARIC ACID
- PHENOXYETHANOL
- ERYTHRITOL
- PEG-75 STEARATE
- SODIUM POLYSTYRENE SULFONATE
- METHYLPARABEN
- TRIFOLIUM PRATENSE FLOWER
- C13-14 ISOPARAFFIN
- SORGHUM BICOLOR STEM JUICE
- PROPYLPARABEN
- XANTHAN GUM
- CETETH-20
- STEARETH-20
- BUTYLENE GLYCOL
- LAURETH-7
- CARBOMER INTERPOLYMER TYPE A (55000 MPA.S)
- EDETATE SODIUM
- DIMETHICONE
- BUTYLPARABEN
- CHLORELLA VULGARIS
- ISOBUTYLPARABEN
- LAURETH-23
- LAURETH-4
- FD&C YELLOW NO. 5
- FD&C RED NO. 4
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 43455-0005 | 43455-0005-0, 43455-0005-1, 43455-0005-2 |
Ingredients#
Every source-derived ingredient row is available through these pages.
Source Document#
Inactive ingredient matches#
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| BUTYLENE GLYCOL | BUTYLENE GLYCOL | 3XUS85K0RA | SYSTEM / TRANSDERMAL | 8.12 mg | ||
| STEARIC ACID | STEARIC ACID | 4ELV7Z65AP | PELLET / SUBCUTANEOUS | 0.97 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SUSPENSION / OPHTHALMIC | 58 mg | ||
| LAURETH-4 | LAURETH-4 | 6HQ855798J | GEL / TOPICAL | 60 mg | ||
| PROPYLPARABEN | PROPYLPARABEN | Z8IX2SC1OH | CREAM / TOPICAL | 6 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | INJECTION / INTRADERMAL | 1.6 %w/v | ||
| FD&C BLUE NO. 1 | FD&C BLUE NO. 1 | H3R47K3TBD | LIQUID / ORAL | NA | ||
| FD&C BLUE NO. 1 | FD&C BLUE NO. 1 | H3R47K3TBD | POWDER, FOR SUSPENSION / ORAL | 1 mg/5ml | ||
| CETYL ALCOHOL | CETYL ALCOHOL | 936JST6JCN | AEROSOL, FOAM / RECTAL | 17 mg | ||
| GLYCERYL MONOSTEARATE | GLYCERYL MONOSTEARATE | 230OU9XXE4 | AEROSOL, FOAM / TOPICAL | 3.27 %w/w | ||
| GLYCERYL MONOSTEARATE | GLYCERYL MONOSTEARATE | 230OU9XXE4 | CAPSULE, DELAYED RELEASE / ORAL | 15 mg | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | JELLY / NASAL | 250 mg | ||
| FD&C BLUE NO. 1 | FD&C BLUE NO. 1 | H3R47K3TBD | CAPSULE, DELAYED RELEASE PELLETS / ORAL | 0.01 mg | ||
| TROLAMINE | TROLAMINE | 9O3K93S3TK | GEL / TRANSDERMAL | 6 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | DROPS / ORAL | 300 mg/1ml | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | SYSTEM / TOPICAL | 42 mg | ||
| PROPYLPARABEN | PROPYLPARABEN | Z8IX2SC1OH | POWDER, FOR SUSPENSION / ORAL | 8 mg | ||
| XANTHAN GUM | XANTHAN GUM | TTV12P4NEE | POWDER, FOR SUSPENSION / ORAL | 600 mg | ||
| CETYL ALCOHOL | CETYL ALCOHOL | 936JST6JCN | SUSPENSION / AURICULAR (OTIC) | 1 %w/v | ||
| FD&C YELLOW NO. 5 | FD&C YELLOW NO. 5 | I753WB2F1M | TABLET, EXTENDED RELEASE / ORAL | 2.03 mg | ||
| CYCLOMETHICONE 5 | CYCLOMETHICONE 5 | 0THT5PCI0R | CREAM, AUGMENTED / TOPICAL | 260 mg | ||
| EDETATE SODIUM | EDETATE SODIUM | MP1J8420LU | INJECTION / INTRAVENOUS | 0.01 %w/v | ||
| PROPYLPARABEN | PROPYLPARABEN | Z8IX2SC1OH | CAPSULE, EXTENDED RELEASE / ORAL | 0.22 mg | ||
| STEARIC ACID | STEARIC ACID | 4ELV7Z65AP | CREAM / VAGINAL | 1088 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | GEL / TRANSDERMAL | 500 mg | ||
| STEARIC ACID | STEARIC ACID | 4ELV7Z65AP | CREAM / TOPICAL | 190 mg | ||
| TROLAMINE | TROLAMINE | 9O3K93S3TK | LIQUID / TOPICAL | NA | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | INJECTION / INTRADERMAL | 1 mg | ||
| PROPYLPARABEN | PROPYLPARABEN | Z8IX2SC1OH | INJECTION / SOFT TISSUE | 0.02 %w/v | ||
| PROPYLPARABEN | PROPYLPARABEN | Z8IX2SC1OH | DROPS / OPHTHALMIC | 0.01 %w/w | ||
| STEARIC ACID | STEARIC ACID | 4ELV7Z65AP | OINTMENT / TOPICAL | 15 %w/w | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOLUTION / ORAL | 32400 mg | ||
| PROPYLPARABEN | PROPYLPARABEN | Z8IX2SC1OH | INJECTION, SOLUTION / INTRAMUSCULAR | 5 mg | ||
| STEARIC ACID | STEARIC ACID | 4ELV7Z65AP | EMULSION / ORAL | NA | ||
| FD&C YELLOW NO. 5 | FD&C YELLOW NO. 5 | I753WB2F1M | TABLET, FILM COATED / ORAL | 1.68 mg | ||
| CETYL ALCOHOL | CETYL ALCOHOL | 936JST6JCN | TABLET, COATED / ORAL | 0.25 mg | ||
| GLYCERYL MONOSTEARATE | GLYCERYL MONOSTEARATE | 230OU9XXE4 | EMULSION / ORAL | NA | ||
| TROLAMINE | TROLAMINE | 9O3K93S3TK | SPRAY / NASAL | NA | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | INJECTION, SOLUTION / EPIDURAL | 30 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | CREAM / VAGINAL | 60 mg | ||
| FD&C YELLOW NO. 5 | FD&C YELLOW NO. 5 | I753WB2F1M | SUPPOSITORY / VAGINAL | NA | ||
| CETYL ALCOHOL | CETYL ALCOHOL | 936JST6JCN | SUSPENSION / OPHTHALMIC | 0.5 %w/v | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | DROPS / AURICULAR (OTIC) | 0.01 %w/w | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | FILM / BUCCAL | 1 mg | ||
| PROPYLPARABEN | PROPYLPARABEN | Z8IX2SC1OH | INJECTION / INTRAVENOUS | 6 mg | ||
| PROPYLPARABEN | PROPYLPARABEN | Z8IX2SC1OH | SOLUTION, CONCENTRATE / ORAL | 0.2 mg/1ml | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | LOTION / TOPICAL | 3990 mg | ||
| CETETH-20 | CETETH-20 | I835H2IHHX | LOTION / TOPICAL | 2 %w/w | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | DROPS / NASAL | 10 mg/1ml | ||
| STEARIC ACID | STEARIC ACID | 4ELV7Z65AP | TABLET / ORAL | 336 mg | ||
| PROPYLPARABEN | PROPYLPARABEN | Z8IX2SC1OH | INJECTION, SUSPENSION / SUBCUTANEOUS | 0.02 %w/v | ||
| PHENOXYETHANOL | PHENOXYETHANOL | HIE492ZZ3T | GEL / TOPICAL | 14 mg | ||
| FD&C BLUE NO. 1 | FD&C BLUE NO. 1 | H3R47K3TBD | TABLET, DELAYED RELEASE / ORAL | 0.01 mg | ||
| STEARIC ACID | STEARIC ACID | 4ELV7Z65AP | EMULSION / TOPICAL | NA | ||
| GLYCERYL MONOSTEARATE | GLYCERYL MONOSTEARATE | 230OU9XXE4 | TABLET / ORAL | 33.34 mg | ||
| FD&C BLUE NO. 1 | FD&C BLUE NO. 1 | H3R47K3TBD | MOUTHWASH / BUCCAL | NA | ||
| XANTHAN GUM | XANTHAN GUM | TTV12P4NEE | AEROSOL, FOAM / TOPICAL | 0.27 %w/w | ||
| EDETATE SODIUM | EDETATE SODIUM | MP1J8420LU | LOTION / TOPICAL | 0.17 %w/w | ||
| GLYCERYL MONOSTEARATE | GLYCERYL MONOSTEARATE | 230OU9XXE4 | SUSPENSION / OPHTHALMIC | 0.5 %w/v | ||
| PROPYLPARABEN | PROPYLPARABEN | Z8IX2SC1OH | TABLET, CHEWABLE / ORAL | 0.14 mg |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| e4fa477d-b315-4e58-a5a9-613f83d0d17a | 09bd9805-9554-45f7-870e-b7f68bd87237 | 2012-03-28 | Warnings | e4fa477d-b315-4e58-a5a9-613f83d0d17a 09bd9805-9554-45f7-870e-b7f68bd87237 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.